Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy, Autologous Stem Cell Transplant, and Rituximab for Mantle Cell Lymphoma
NCT00020943Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2001
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab in mantle cell lymphoma (MCL), sponsored by Cancer and Leukemia Group B. Started Jun 2001; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00020943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020943.